Azora Capital LP Raises Holdings in Enfusion, Inc. (NYSE:ENFN)

Azora Capital LP boosted its stake in Enfusion, Inc. (NYSE:ENFN) by 3,255.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,000,967 shares of the company’s stock after acquiring an additional 971,140 shares during the period. Azora Capital LP’s holdings in Enfusion were worth $10,310,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of ENFN. KLP Kapitalforvaltning AS acquired a new position in shares of Enfusion in the fourth quarter worth $75,000. Dark Forest Capital Management LP acquired a new stake in shares of Enfusion during the fourth quarter valued at $128,000. Tower Research Capital LLC TRC increased its position in Enfusion by 58.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 13,227 shares of the company’s stock worth $136,000 after purchasing an additional 4,889 shares in the last quarter. Quantbot Technologies LP acquired a new position in Enfusion in the 4th quarter valued at about $144,000. Finally, Aquatic Capital Management LLC lifted its holdings in Enfusion by 2,013.2% in the 4th quarter. Aquatic Capital Management LLC now owns 15,828 shares of the company’s stock valued at $163,000 after purchasing an additional 15,079 shares in the last quarter. Institutional investors and hedge funds own 81.05% of the company’s stock.

Insider Buying and Selling at Enfusion

In related news, CEO Oleg Movchan sold 2,790 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $11.48, for a total value of $32,029.20. Following the transaction, the chief executive officer now directly owns 643,299 shares of the company’s stock, valued at approximately $7,385,072.52. This trade represents a 0.43 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Neal Pawar sold 14,560 shares of Enfusion stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $11.38, for a total value of $165,692.80. Following the completion of the transaction, the chief operating officer now owns 1,217,067 shares in the company, valued at $13,850,222.46. The trade was a 1.18 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 66,223 shares of company stock worth $754,778 in the last quarter. 36.44% of the stock is owned by insiders.

Enfusion Trading Up 0.5 %

NYSE ENFN opened at $10.85 on Friday. The business’s 50-day moving average price is $11.01 and its 200 day moving average price is $10.55. Enfusion, Inc. has a twelve month low of $7.83 and a twelve month high of $11.80. The company has a market capitalization of $1.40 billion, a PE ratio of 271.29, a price-to-earnings-growth ratio of 1.85 and a beta of 0.92.

Enfusion (NYSE:ENFN) last announced its quarterly earnings data on Monday, March 3rd. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.02). Enfusion had a return on equity of 6.67% and a net margin of 1.70%. The company had revenue of $52.94 million for the quarter, compared to analysts’ expectations of $53.98 million. Equities analysts predict that Enfusion, Inc. will post 0.06 EPS for the current year.

Wall Street Analyst Weigh In

Separately, William Blair reissued a “market perform” rating on shares of Enfusion in a research report on Monday, January 13th.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.